World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
IMVTImmunovant | $3.71bn | n/a | n/a |
MRUSMerus NV | $3.59bn | n/a | n/a |
CRNXCrinetics Pharmaceuticals | $3.50bn | n/a | n/a |
BGBIOBergenbio ASA | NOK34.95bn | n/a | n/a |
RAREUltragenyx Pharmaceutical | $3.34bn | n/a | n/a |
GHGuardant Health | $3.32bn | n/a | n/a |
SYNGENESyngene International | IN₹267.22bn | 51.55 | 0.19% |
DYNDyne Therapeutics | $3.11bn | n/a | n/a |
BHVNBiohaven | $3.10bn | n/a | n/a |
SWTXSpringWorks Therapeutics | $3.07bn | n/a | n/a |
FOLDAmicus Therapeutics | $2.90bn | n/a | n/a |
KDNYChinook Therapeutics | $2.90bn | n/a | n/a |
XENEXenon Pharmaceuticals | $2.87bn | n/a | n/a |
ARWRArrowhead Pharmaceuticals | $2.85bn | n/a | n/a |
MORMorphosys AG | €2.59bn | n/a | n/a |
PTCTPTC Therapeutics | $2.79bn | n/a | n/a |
ACLXArcellx | $2.78bn | n/a | n/a |
JANXJanux Therapeutics | $2.77bn | n/a | n/a |
IDYAIdeaya Biosciences | $2.77bn | n/a | n/a |
AZTAAzenta | $2.72bn | n/a | n/a |